# Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke

> **NCT07357987** · PHASE3 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 488 (estimated)

## Conditions studied

- Ischemic Stroke
- Medium Vessel Occlusion
- Tenecteplase
- Endovascular Treatment

## Interventions

- **PROCEDURE:** Intra-arterial Tenecteplase
- **DRUG:** standard medical management

## Key facts

- **NCT ID:** NCT07357987
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-22
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 488 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07357987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07357987, "Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07357987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*